Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Debt: 2018-2020

  • Neurocrine Biosciences' Total Debt was N/A to $425.0 million in Q3 2020 from the same period last year, while for Dec 2019 it was $408.8 million, marking a year-over-year change of. This contributed to the annual value of $408.8 million for FY2019, which is N/A change from last year.
  • As of Q3 2020, Neurocrine Biosciences' Total Debt stood at $425.0 million, which was up 1.31% from $419.5 million recorded in Q2 2020.
  • Neurocrine Biosciences' Total Debt's 5-year high stood at $425.0 million during Q3 2020, with a 5-year trough of $383.6 million in Q3 2018.
  • Its 3-year average for Total Debt is $409.2 million, with a median of $414.1 million in 2019.